Contineum Therapeutics, Inc. Class A Balance Sheet
Contineum Therapeutics, Inc. Class A's total assets for Q4 2025 were $276.64M, an increase of 44.95% from the previous quarter. CTNM total liabilities were $15.65M for the fiscal quarter, a 50.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Total Assets
$ 276.64M
$ 212.85M
$ 130.39M
$ 50.64M
$ 70.52M
Total Liabilities
$ 15.65M
$ 14.78M
$ 198.32M
$ 11.37M
$ 8.93M
Total Equity Gross Minority
$ 260.99M
$ 198.07M
$ -67.94M
$ 39.27M
$ 61.59M
Other Metrics
Currency in USD
Contineum Therapeutics, Inc. Class A Debt to Assets